ASHP Advantage's Engaging the Experts
39 episodes - English - Latest episode: about 4 years ago - ★★★★★ - 4 ratingsPodcast programs produced by ASHP Advantage for health care professionals.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Strategies for Prevention and Treatment of Recurrent C. difficile Infection
April 28, 2020 19:12 - 21 minutes - 14.5 MBWilliam Zellmer talks with Kevin Garey and Pablo Okhuysen about strategies for prevention and treatment of recurrent Clostridioides difficile infection.
Using Immune Checkpoint Inhibitors to Treat Lung Cancer and Melanoma
April 28, 2020 19:12 - 14 minutes - 9.93 MBWilliam Zellmer talks with Christine Walko and Shetal Patel about immune checkpoint inhibitors.
Revised USP Chapter 797 (Part 3): Practical Approaches to Attaining Compliance
July 22, 2019 22:42 - 17 minutes - 12 MBIn Part 3 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about practical approaches for attaining compliance.
Revised USP Chapter <797> (Part 3): Practical Approaches to Attaining Compliance
July 22, 2019 22:42 - 17 minutes - 12 MBIn Part 3 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about practical approaches for attaining compliance.
Revised USP Chapter <797> (Part 2): Getting Your Facility Ready
July 22, 2019 22:41 - 20 minutes - 13.8 MBIn Part 2 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about changes that may be needed to get your facility ready.
Revised USP Chapter 797 (Part 2): Getting Your Facility Ready
July 22, 2019 22:41 - 20 minutes - 13.8 MBIn Part 2 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about changes that may be needed to get your facility ready.
Revised USP Chapter 797 (Part 1): Overview of Changes
July 22, 2019 22:39 - 15 minutes - 10.6 MBIn Part 1 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about key changes to note.
Revised USP Chapter <797> (Part 1): Overview of Changes
July 22, 2019 22:39 - 15 minutes - 10.6 MBIn Part 1 of this three-part interview on revised USP Chapter <797>, William Zellmer talks with Patricia Kienle, Ashley Duty, and Eric Kastango about key changes to note.
Integrating Gene Therapies into Pharmacy Practice
January 18, 2019 20:13 - 19 minutes - 4.38 MBWilliam Zellmer talks with John Petrich and Michael Storey about gene therapies and considerations for integrating them into pharmacy practice.
Insourcing Sterile i.v. Compounding Service: Emory University Hospital Midtown Profile
April 26, 2017 21:47 - 27 minutes - 18.8 MBAngela Cassano talks with Ryan Forrey about insourcing compounded sterile products and how he addressed the challenges faced at Emory University Hospital Midtown.
Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 2 of 2)
February 28, 2017 15:54 - 26 minutes - 12.3 MBPart 2: Future Treatment Options and Roles for Pharmacists in Individualizing Insulin Therapy In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding future treatment options for type 2 diabetes and the roles for pharmacists in individualizing insulin therapy. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associat...
Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 1 of 2)
February 28, 2017 15:52 - 21 minutes - 9.72 MBPart 1: Barriers to Optimizing the Use of Insulin in Managing Type 2 Diabetes In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding the barriers to optimizing the use of insulin in managing patients with type 2 diabetes. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc. Faculty: Curtis Triplitt, PharmD, CDE Associate Director, Diabetes Research Center, T...
Biosimilars: Current Status in the European Union and United States (Part 1 of 2)
February 05, 2016 18:49 - 18 minutes - 8.66 MBIn Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding the status of biosimilars in the European Union and United States. Faculty: Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair Associate Professor Department of Pharmacy Practice University of New England College of Pharmacy Portland, Maine James G. Stevenson, Pharm.D., FASHP Professor, Department of Clinical Pharmacy University of Michigan College of ...
Biosimilars: Focus on Interchangeability and Integration into the Medication-use System (Part 2 of 2)
February 05, 2016 18:49 - 15 minutes - 6.95 MBIn Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding biosimilars, focusing on interchangeability and the integration of biosimilars into the medication-use system. Faculty: Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair Associate Professor Department of Pharmacy Practice University of New England College of Pharmacy Portland, Maine James G. Stevenson, Pharm.D., FASHP Professor, Department of Clinical ...
Focus on SGLT2 inhibitors for Diabetes Part 2 of 2
March 03, 2015 17:33 - 9 minutes - 3.88 MBWilliam Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice. Faculty: Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, Activity Chair Assistant Director of Experiential Education Associate Professor Department of Pharmacy Practice Midwestern University Chicago College of Pharm...
Focus on SGLT2 inhibitors for Diabetes Part 1 of 2
March 03, 2015 17:32 - 7 minutes - 3.01 MBWilliam Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice. Faculty: Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, Activity Chair Assistant Director of Experiential Education Associate Professor Department of Pharmacy Practice Midwestern University Chicago College of Pharm...
Improving Hyponatremia Management Part 2 of 2
March 03, 2015 17:21 - 12 minutes - 4.94 MBWilliam Zellmer discusses issues related to improving hyponatremia management in hospitalized patients with Joseph Dasta and Gretchen Brophy. They explore how findings from a hyponatremia registry and disease-based medication-use evaluations of hyponatremia can help identify areas of patient care needing improvement. Faculty: Joseph F. Dasta, M.S., MCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Adjunct Professor The University of Texas Coll...
Improving Hyponatremia Management Part 1 of 2
March 03, 2015 17:20 - 12 minutes - 5.16 MBWilliam Zellmer discusses issues related to improving hyponatremia management in hospitalized patients with Joseph Dasta and Gretchen Brophy. They explore how findings from a hyponatremia registry and disease-based medication-use evaluations of hyponatremia can help identify areas of patient care needing improvement. Faculty: Joseph F. Dasta, M.S., MCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Adjunct Professor The University of Texas Coll...
New and Emerging Strategies for the Treatment of Advanced Melanoma
March 03, 2015 17:17 - 16 minutes - 3.75 MBWilliam Zellmer discusses therapeutic options for treating patients with advanced melanoma with Christine Walko and R. Donald Harvey. They explore the epidemiology of melanoma including risk factors for developing the disease and discuss broad categories of new treatments and specific agents in each category. Faculty: Christine M. Walko, Pharm.D., BCOP, FCCP Clinical Pharmacogenomic Scientist Moffitt Cancer Center Associate Professor University of South Florida Morsani College of Medi...
The Role of the Pharmacist in ABSSSI and CABP - Taking Action (Part 3 of 3)
June 20, 2014 17:53 - 11 minutes - 4.91 MBNeil A. Davis is interviewed by John Esterly on the topic of the role of pharmacists in treating acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP). The interview was conducted in January 2014. Faculty: Neil A. Davis, Pharm.D. Clinical Pharmacy Coordinator, Critical Care Specialist, and Antibiotic Stewardship Co-chair Sentara Healthcare Virginia Beach, Virginia John Esterly, Pharm.D., BCPS (AQ-ID), Activity Chair Assistan...
Controversies and Conundrums in the Treatment of Community-acquired Bacterial Pneumonia (Part 2 of 3)
June 20, 2014 17:51 - 12 minutes - 4.91 MBScott Bergman is interviewed by John Esterly and address controversies and conundrums in the treatment of community-acquired bacterial pneumonia (CABP). The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Scott Bergman, Pharm.D., BCPS (AQ-ID) Associate Professor Southern Illinois University Edwardsville Clinical Pharmacy Specialist and PGY2 Infectious Diseases Residency Program Director St. John’s Hospital Springfield, Illinois John Ester...
Considerations for Incorporating New ABSSSI and CABP Treatment Options into Clinical Practice (Part 1 of 3)
June 20, 2014 17:49 - 12 minutes - 5.06 MBJohn Esterly is interviewed by Scott Bergman and discusses considerations for incorporating new acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) treatment options into the pharmacist’s practice. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: John Esterly, Pharm.D., BCPS (AQ-ID), Activity Chair Assistant Professor, Pharmacy Practice Chicago State University College of Pharmac...
Optimizing Postoperative Pain Management: Considerations Related to the Use of Local Anesthetics (Part 3 of 3)
February 26, 2014 23:33 - 10 minutes - 4.35 MBJulie Golembiewski conducts a roundtable discussion with Virginia Ghafoor and Leslie Schechter about the use of local anesthetics in managing postoperative pain, focusing on safety and logistical issues related to newer agents. The roundtable was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Julie Golembiewski, Pharm.D., FASHP, Activity Chair Clinical Pharmacist, Anesthesia and Pain University of Illinois Hospital and Health Sciences System Clinical Asso...
Optimizing Postoperative Pain Management: Role of Pharmacists (Part 2 of 3)
February 26, 2014 23:32 - 6 minutes - 2.57 MBJulie Golembiewski conducts a roundtable discussion with Virginia Ghafoor and Leslie Schechter about the role pharmacists can play in optimizing the management of postoperative pain. The roundtable was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Julie Golembiewski, Pharm.D., FASHP, Activity Chair Clinical Pharmacist, Anesthesia and Pain University of Illinois Hospital and Health Sciences System Clinical Associate Professor Colleges of Pharmacy and Med...
Optimizing Postoperative Pain Management: Multimodal Therapy (Part 1 of 3)
February 26, 2014 23:30 - 7 minutes - 2.84 MBJulie Golembiewski conducts a roundtable discussion with Virginia Ghafoor and Leslie Schechter about the benefits of using multimodal therapy for managing postoperative pain. The roundtable was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Julie Golembiewski, Pharm.D., FASHP, Activity Chair Clinical Pharmacist, Anesthesia and Pain University of Illinois Hospital and Health Sciences System Clinical Associate Professor Colleges of Pharmacy and Medicine U...
Optimizing Postoperative Pain Management: Multimodal Therapy (Part 1 of 3)
February 26, 2014 23:30 - 7 minutes - 2.84 MBJulie Golembiewski conducts a roundtable discussion with Virginia Ghafoor and Leslie Schechter about the benefits of using multimodal therapy for managing postoperative pain. The roundtable was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Julie Golembiewski, Pharm.D., FASHP, Activity Chair Clinical Pharmacist, Anesthesia and Pain University of Illinois Hospital and Health Sciences System Clinical Associate Professor Colleges of Pharmacy and Medicine U...
Rational Management of Hospitalized Patients with Hyponatremia: Role of the Pharmacist (Part 3 of 3)
February 26, 2014 23:28 - 10 minutes - 4.15 MBJoseph Dasta conducts a roundtable discussion with Amy Dzierba and Jodie Pepin about the role of pharmacists in managing hyponatremia in hospitalized patients, including considerations related to transition of care after discharge. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Adjunct Professor The University of Texas Coll...
Rational Management of Hospitalized Patients with Hyponatremia: Focus on Critically Ill Patients (Part 2 of 3)
February 26, 2014 23:26 - 9 minutes - 3.86 MBJoseph Dasta conducts a roundtable discussion with Amy Dzierba and Jodie Pepin about managing hyponatremia in critically ill patients, especially factors affecting the rate of serum sodium correction. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Adjunct Professor The University of Texas College of Pharmacy Austin, Texas ...
Rational Management of Hospitalized Patients with Hyponatremia: Developing Hyponatremia Protocols in Institutions (Part 1 of 3)
February 26, 2014 23:25 - 8 minutes - 3.26 MBJoseph Dasta conducts a roundtable discussion with Amy Dzierba and Jodie Pepin about considerations in developing protocols for managing hospitalized patients with hyponatremia. The roundtable was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Amy L. Dzierba, Pharm...
Managing Hyperglycemia in Inpatients: Meeting the Needs of Special Populations (Part 3 of 3)
February 26, 2014 22:57 - 11 minutes - 4.54 MBPaul Szumita discusses with Carla Brink, Scientific Project Director for ASHP, considerations for managing hyperglycemia in hospitalized patients who are critically ill, do or do not have a previous diagnosis of diabetes mellitus, or are receiving parenteral or enteral nutrition. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Paul M. Szumita, Pharm.D., BCPS Clinical Pharmacy Practice Manager Director, Critical Care Pharmacy Residency Bri...
Managing Hyperglycemia in Inpatients: Using Data to Facilitate Changes (Part 2 of 3)
February 26, 2014 22:56 - 17 minutes - 7.18 MBKevin Box discusses with Carla Brink, Scientific Project Director for ASHP, what metrics to collect and then how to use them to facilitate improvements in glycemic control for hospitalized patients. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Kevin W. Box, Pharm.D. Senior Clinical Pharmacist UC San Diego Health System San Diego, California C.E. Credits: This activity is not eligible for continuing education credits.
Managing Hyperglycemia in Inpatients: Understanding the Guidelines (Part 1 of 3)
February 26, 2014 22:34 - 11 minutes - 4.44 MBCurtis Triplitt discusses with Carla Brink, Scientific Project Director for ASHP, recommended target glucose levels in guidelines for inpatient glycemic control. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Curtis L. Triplitt, Pharm.D., CDE, Activity Chair Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at ...
Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 1 of 3)
February 02, 2013 19:06 - 15 minutes - 6.25 MBChallenges in Managing Acute Bleeding in Patients with Hemophilia (Part 1 of 3) Part 1: Monitoring and Dosing Considerations Faculty: William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specialist UC Davis Medical Center Sacramento, California Mark T. Reding, M.D. Director, Center for Bleeding and Clotting Disorders University of Minnesota Medical Center, Fairview Associate Professor University of Minnesota Medical School Minneapolis, Minnesota C.E. Credits: This activit...
Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 2 of 3)
February 02, 2013 19:06 - 13 minutes - 5.32 MBChallenges in Managing Acute Bleeding in Patients with Hemophilia (Part 2 of 3) Part 2: Considerations in Controlling Bleeding and Preventing Thrombosis Faculty: William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specialist UC Davis Medical Center Sacramento, California Mark T. Reding, M.D. Director, Center for Bleeding and Clotting Disorders University of Minnesota Medical Center, Fairview Associate Professor University of Minnesota Medical School Minneapolis, Minnesota...
Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 3 of 3)
February 02, 2013 19:05 - 15 minutes - 6.25 MBChallenges in Managing Acute Bleeding in Patients with Hemophilia (Part 3 of 3) Part 3: Monitoring and Dosing Considerations Faculty: William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specialist UC Davis Medical Center Sacramento, California Surabhi Palkimas, Pharm.D. Pharmacy Clinical Coordinator, Hematology University of Virginia Health System Charlottesville, Virginia C.E. Credits: This activity is not eligible for continuing education credits.
Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 1 of 3)
February 01, 2013 16:51 - 14 minutes - 5.86 MBEmerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 1 of 3) Part 1: Issues Related to Warfarin Reversal Faculty: Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator Clinical Professor The University of Illinois at Chicago College of Pharmacy Director, Antithrombosis Center The University of Illinois Hospital and Health Sciences System Chicago, Illinois William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specialis...
Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 2 of 4)
February 01, 2013 16:51 - 9 minutes - 3.8 MBEmerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 2 of 4) Part 2: Usefulness of Coagulation Assays in Patients taking Target-Specific Oral Anticoagulants Faculty: Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator Clinical Professor The University of Illinois at Chicago College of Pharmacy Director, Antithrombosis Center The University of Illinois Hospital and Health Sciences System Chicago, Illinois William E. Dager, ...
Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 3 of 4)
February 01, 2013 16:50 - 14 minutes - 5.86 MBEmerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 3 of 4) Part 3: Balancing Bleeding and Thrombosis Risk Faculty: Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator Clinical Professor The University of Illinois at Chicago College of Pharmacy Director, Antithrombosis Center The University of Illinois Hospital and Health Sciences System Chicago, Illinois William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specia...
Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 4 of 4)
February 01, 2013 16:50 - 9 minutes - 3.99 MBEmerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 4 of 4) Part 4: Reversal of Target-specific Oral Anticoagulants Faculty: Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator Clinical Professor The University of Illinois at Chicago College of Pharmacy Director, Antithrombosis Center The University of Illinois Hospital and Health Sciences System Chicago, Illinois William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmaci...